Zhang, J., Mu, Y., Zhang, H., Deng, C., Yang, J., Gan, L., . . . Xu, L. (2025). Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting. Frontiers in Oncology, 15, . https://doi.org/10.3389/fonc.2025.1564888
Chicago-referens (17:e uppl.)Zhang, Jian, et al. "Efficacy and Safety of Inetetamab-containing Regimens in Patients with HER2-positive Metastatic Breast Cancer in First-line/second-line Setting." Frontiers in Oncology 15 (2025). https://doi.org/10.3389/fonc.2025.1564888.
MLA-referens (9:e uppl.)Zhang, Jian, et al. "Efficacy and Safety of Inetetamab-containing Regimens in Patients with HER2-positive Metastatic Breast Cancer in First-line/second-line Setting." Frontiers in Oncology, vol. 15, 2025, https://doi.org/10.3389/fonc.2025.1564888.
